[Changes caused by hydergine and dihydroengotamine in intracranial periperipheral circulation].
D001686:Biological Phenomena; D002317:Cardiovascular Agents; D002319:Cardiovascular System; D004877:Ergoloid Mesylates; D004876:Ergot Alkaloids / Q000494:pharmacology*; D012160:Retina / Q000098:blood supply*
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D004877:Ergoloid Mesylates
ERGOT ALKALOIDS/effects; RETINA/blood supply
Klin Wochenschr. 1951 Sep 1;29(33-34):580-1
14881442
Doc Ophthalmol. 1951;5-6:357-402
14896881
Schweiz Med Wochenschr. 1947 Jul 19;77(29):769-71
20258099
Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1951;187(2):153-64
14924626
Helv Med Acta. 1951 Oct;18(4-5):553-8
14873196
J Clin Invest. 1950 Apr;29(4):408-11
15415441
J Clin Invest. 1948 Jul;27(4):476-83
16695568
Br Heart J. 1952 Jan;14(1):77-86
14904818
Helv Physiol Pharmacol Acta. 1952;10(2):120-37
14937498
Schweiz Med Wochenschr. 1946 Dec 7;76(49):1263-6
20296721
Helv Physiol Pharmacol Acta. 1951 Jun;9(2):C 37-9
14849976
Ophthalmologica. 1952 Jul;124(1):1-11
12983044
Uber die Veränderungen am Intrakraniellen peripheren Kreislauf durch Hydergin und Dihydroergotamin.